No Data
China Grand Pharmaceutical and Healthcare Holdings Limited (01672.HK) spent 0.993 million Hong Kong dollars to repurchase 0.6 million shares on November 27th.
GLEAM Pharmaceuticals-B (01672.HK) announced on November 27th that it spent 0.993 million Hong Kong dollars to repurchase 0.6 million shares.
On November 26, 2023, Kereon Pharmaceuticals-B (01672.HK) spent 0.336 million Hong Kong dollars to repurchase 0.2 million shares.
On November 26, Gelesis Pharmaceuticals-B (01672.HK) announced that it spent 0.336 million Hong Kong dollars to repurchase 0.2 million shares on November 26.
China Resources Pharmaceutical Group Limited -B(01672.HK) spent 0.513 million Hong Kong dollars to repurchase 0.3 million shares on November 25th.
On November 25, GeLi Pharmaceutical-B (01672.HK) announced that it repurchased 0.3 million shares for 0.513 million Hong Kong dollars on November 25th.
On November 21, Gilead Sciences-B (01672.HK) spent 0.128 million Hong Kong dollars to repurchase 0.076 million shares.
Gelonghui, November 21丨Eagle Pharma-B (01672.HK) announced that on November 21, 2024, it spent 0.128 million HKD to repurchase 0.076 million shares, with a repurchase price of 1.67-1.7 HKD per share.
On November 20, Gilead Sciences-B (01672.HK) spent 0.499 million Hong Kong dollars to repurchase 0.3 million shares.
Gelonghui, November 20丨Galactrum Pharmaceuticals-B (01672.HK) announced that on November 20, it spent 0.499 million Hong Kong dollars to repurchase 0.3 million shares.
China Grand Pharmaceutical and Healthcare Holdings Limited (01672.HK) spent 0.5022 million Hong Kong dollars on repurchasing 0.3 million shares on November 19th.
On November 19, Gelonghui reported that Gilead Sciences-B (01672.HK) announced the repurchase of 300,000 shares at a cost of HK$0.5022 million on November 19, 2024, with a repurchase price ranging from HK$1.65 to HK$1.68 per share.
No Data
No Data
